The National Institute of Allergy and Infectious Diseases (NIAID) Clinical Center Research Program conducts clinical research with the goal of obtaining information that will lead to a better understanding of infectious disease, healthy volunteers and HIV infection—and its treatment and prevention.
Our clinical trials must be conducted according to a written document called a protocol. A protocol must be approved by the NIAID Institutional Review Board (IRB), which is charged with protecting the rights of people who participate in studies.
Because people from across the United States can participate in most of our studies, it is important that we be able to communicate with their physicians. This helps to ensure the safety of our participants.
back to top
Last Updated October 20, 2011